Price target
166.410.000.00%
The 24 analysts offering 1 year price forecasts for NBIX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 27 analysts giving stock ratings to NBIX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NBIX EPS for the last quarter is 1.24 USD despite the estimation of 1.51 USD. In the next quarter EPS is expected to reach 1.57 USD. Track more of Neurocrine Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Neurocrine Biosciences, Inc. revenue is expected to reach 630.01 M USD. Check out Neurocrine Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, NBIX price target is 166.41 USD with a max estimate of 192.00 USD and a min estimate of 121.00 USD. Check if this forecast comes true in a year, meanwhile watch Neurocrine Biosciences, Inc. stock price chart and keep track of the current situation with NBIX news and stock market news.
We've gathered opinions of 27 analysts rating NBIX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.